As the safety, quality and compliance requirements for home medical devices in the Middle East and the Gulf Region (GCC) continue to increase, the market is accelerating from "price-oriented" to "quality and trust-oriented".
With an established compliance framework and high-standard quality management systems, MLAY continues to align its products and operations with regional regulatory and certification requirements. The company also takes into account local cultural considerations and usage habits, including relevant Halal requirements, while integrating compliance throughout its operations to help ensure product safety and quality. This approach has enabled MLAY to build long-term trust among consumers and business partners.
Multi-dimensional certification solidifies the foundation and builds an internationally recognized "management moat."
In response to increasingly stringent safety, quality, and compliance requirements in the Middle East market, MLAY continues to strengthen its international certifications and quality management systems, while maintaining a long-term commitment to regulatory compliance in the region.
Years ago, MLAY obtained Saudi Food and Drug Authority (SFDA) certification, along with multiple internationally recognized certifications and management standards, including ISO 13485, MDSAP, FDA, and CE. These certifications have established a solid compliance foundation for the company’s continued expansion across the Middle East and global markets.
Meanwhile, management systems and standards including BSCI, ISO 45001, and ISO 14001 further strengthen MLAY ’s production and supply chain management. Covering key stages from R&D and manufacturing to quality control and after-sales service, these systems support consistent product safety and quality in line with international standards, providing reliable assurance for consumers and partners in the Middle East.
A foundation of quality, full-lifecycle quality control, and a solid basis for compliance
MLAY integrates compliance requirements throughout its R&D, manufacturing, and inspection processes, using digital technologies to enhance traceability across production. Through the implementation of MES and ERP systems, the company manages individual products and production processes with greater precision, enabling full-lifecycle quality control through a “one product, one code” traceability system.
Under its comprehensive quality control framework, MLAY ’s laboratory serves as a key quality assurance center, where every new material and product batch undergoes 100% rigorous testing. Testing includes fatigue-resistance verification through 10,000 cable-bending cycles, 1,000-hour aging tests for optical components, and simulated transportation stress tests under extreme environmental conditions.
These multi-stage testing procedures add multiple layers of safety and quality assurance, helping ensure that compliance requirements are incorporated into product development and manufacturing down to the technical details.
Regulatory compliance: an end-to-end closed loop spanning from manufacturing to marketing and promotion
In response to evolving regulatory requirements, MLAY has established a dedicated marketing communications review process to ensure that external communications are truthful, accurate, and compliant. This approach helps identify and address potential legal and reputational risks at an early stage.
MLAY recognizes that, in an increasingly competitive global market, compliance and quality are essential to building long-term market trust and supporting sustainable growth.
Looking ahead, MLAY will continue to uphold high standards, deepen its digital transformation, and strengthen its compliance and quality management capabilities. The company is committed to providing global consumers with safer, more effective, and compliant home-use medical devices, while working toward its vision of becoming a respected global medical technology company.
